| 000 | 01855 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517150217.0 | ||
| 264 | 0 | _c20170908 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1097-4164 | ||
| 024 | 7 |
_a10.1016/j.molcel.2017.03.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Wei | |
| 245 | 0 | 0 |
_aStructural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. _h[electronic resource] |
| 260 |
_bMolecular cell _cApr 2017 |
||
| 300 |
_a169-179.e8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xmetabolism |
| 650 | 0 | 4 |
_aBacterial Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aDNA-Directed RNA Polymerases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aGene Expression Regulation, Bacterial _xdrug effects |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aRifampin _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 700 | 1 | _aMandal, Soma | |
| 700 | 1 | _aDegen, David | |
| 700 | 1 | _aLiu, Yu | |
| 700 | 1 | _aEbright, Yon W | |
| 700 | 1 | _aLi, Shengjian | |
| 700 | 1 | _aFeng, Yu | |
| 700 | 1 | _aZhang, Yu | |
| 700 | 1 | _aMandal, Sukhendu | |
| 700 | 1 | _aJiang, Yi | |
| 700 | 1 | _aLiu, Shuang | |
| 700 | 1 | _aGigliotti, Matthew | |
| 700 | 1 | _aTalaue, Meliza | |
| 700 | 1 | _aConnell, Nancy | |
| 700 | 1 | _aDas, Kalyan | |
| 700 | 1 | _aArnold, Eddy | |
| 700 | 1 | _aEbright, Richard H | |
| 773 | 0 |
_tMolecular cell _gvol. 66 _gno. 2 _gp. 169-179.e8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molcel.2017.03.001 _zAvailable from publisher's website |
| 999 |
_c27064099 _d27064099 |
||